🇺🇸 FDA

Intelligence · Clinical Pipeline

R&D Pipeline Programs

ClinicalTrials.gov programs linked to pharma sponsors — phase, modality, and trial IDs for BD and competitive intelligence.

Programs indexed
20,548
Companies
1,769
Drugs tracked
4,797

Quick answer

NovaPharmaNews tracks 20,548 pharmaceutical R&D pipeline programs sourced from ClinicalTrials.gov, linked to sponsor companies. Each profile includes development phase, modality, trial status, NCT identifiers, and indication text — searchable for business development and competitive intelligence.

1,413 results for “Chinese” Clear

  1. Supportive care+Prednisone

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Minimal Change Disease

    phase 3 small molecule active

    1 trial

  2. Suzhou Sceneray® DBS System

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Opiate Addiction

    phase 3 other active

    1 trial

  3. Systematic oral health education

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Malignant Tumor of Head and/or Neck

    phase 3 other completed

    1 trial

  4. TCM

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Non-small Cell Lung Cancer

    phase 3 small molecule active

    1 trial

  5. TPO

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Sepsis

    phase 3 small molecule active

    1 trial

  6. Tacrolimus

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Liver Transplantation

    phase 3 small molecule active

    1 trial

  7. Tacrolimus capsule

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Myasthenia Gravis

    phase 3 small molecule completed

    1 trial

  8. Tacrolimus capsules

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Lupus Nephritis

    phase 3 small molecule completed

    1 trial

  9. Tamoxifen

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Breast Cancer Female

    phase 3 small molecule active

    1 trial

  10. Tang-min Lin pill

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Type 2 Diabetes

    phase 3 small molecule active

    1 trial

  11. Tegafur-Gimeracil-Oteracil Potassium

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Stomach Neoplasm

    phase 3 small molecule completed

    1 trial

  12. Tenecteplase (0.0938mg/kg)

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Stroke

    phase 3 small molecule active

    1 trial

  13. Tenecteplase (TNK) (0.25 mg/kg, to maximum of 25mg)

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Acute Ischemic Stroke

    phase 3 small molecule active

    1 trial

  14. Thoracoscopic Bullectomy Surgery

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Stability During Surgical Operation

    phase 3 other active

    1 trial

  15. Ticagrelor and Aspirin

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Stroke

    phase 3 small molecule completed

    1 trial

  16. Tislelizumab

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Locally Advanced Rectal Carcinoma

    phase 3 small molecule active

    1 trial

  17. Tislelizumab

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Colonic Neoplasms

    phase 3 small molecule active

    1 trial

  18. Tislelizumab（neoadjuvant）

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Head and Neck Squamous Cell Carcinomas

    phase 3 small molecule active

    1 trial

  19. Tissue Plasminogen Activator

    Chinese University of Hong Kong

    Pleural Infection

    phase 3 small molecule active

    1 trial

  20. Tissue Plasminogen Activator (Alteplase)

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Stroke

    phase 3 small molecule completed

    1 trial

  21. Topical application of Periplaneta americana-derived Meilian Fuxin Solution

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Radiation-induced Dermatitis

    phase 3 small molecule active

    1 trial

  22. Toripalimab

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Non Small Cell Lung Cancer

    phase 3 small molecule active

    1 trial

  23. Toripalimab

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Nasopharyngeal Carcinoma

    phase 3 small molecule active

    2 trials

  24. Traditional Chinese Medicine Prescription

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    COVID-19

    phase 3 small molecule active

    1 trial

Frequently asked questions

What is the NovaPharmaNews pipeline directory?

It is a searchable index of 20,548 clinical development programs grouped by sponsor company, with phase (Phase 1–3), modality, trial status, and linked NCT IDs from ClinicalTrials.gov.

Where does pipeline data come from?

Program records are derived from ClinicalTrials.gov and linked to NovaPharmaNews company profiles. Trial status and phase reflect registry data at last sync — verify on ClinicalTrials.gov before investment or partnering decisions. See our data sources page for attribution.

How do I find pipeline programs by company or phase?

Use the search box to match program name, indication, company name, or slug. Results are ordered with late-stage (Phase 3) programs first. Open any row to view the full program profile under its sponsor company.

Data attribution and licensing: Data sources